Learn how QIAGEN helps to make improvements in life possible through our Sample to Insight...

Learn more about working at QIAGEN and what makes our people special. For more information about...

Learn more about QIAGEN's presence at key scientific conferences in 2018

Interview with Peer Schatz, CEO of QIAGEN, about the importance of the ASCO annual meeting and...

Introducing the next generation of syndromic insights. The launch of QIAstat-Dx at ECCMID 2018....

Thank you San Antonio for a wonderful AMP 2018. We already look forward to next year in...

Prof. Dr. Paul Hofman, Head of the Laboratory of Clinical and Experimental Pathology at the...

Prof. Thibault performed a study comparing the results of the new respiratory panel on the...

Dr. Marius Ilié, pathologist at the CHU Nice, France, comments on the role of novel molecular...

Tuberculosis is an ongoing and global epidemic – one of every four people worldwide carries...

Is your doctor or employer asking you to take a test for TB infection? QIAGEN’s QuantiFERON-TB...

The GeneReader NGS System is the world's first truly complete next-generation sequencing (NGS)...

The Integration Fund Hilden (IFH) supports the integration of refugees into the local labor market.

Der Integrations-Fonds Hilden (IFH) unterstützt Flüchtlinge bei der Integration in den lokalen...

Erfahren Sie mehr über das GeneReader NGS System - die weltweit erste Komplettlösung von der...